Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using

Daisuke Wakura1, Takuya Kotani1, Tohru Takeuchi1

  • 1Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka, Japan.

Plos One
|July 8, 2016
PubMed
Abstract

Insights

Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) can differentiate polymyalgia rheumatica (PMR) from elderly-onset rheumatoid arthritis (EORA). PMR patients show significantly higher abnormal FDG accumulation at specific sites, indicating enthesitis.

Area of Science:

  • Rheumatology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Differentiating polymyalgia rheumatica (PMR) from elderly-onset rheumatoid arthritis (EORA) presents clinical challenges.
  • FDG-PET/CT imaging offers a potential tool for distinguishing these conditions.

Purpose of the Study:

  • To compare FDG-PET/CT findings between PMR and EORA patients.
  • To identify imaging features that aid in differentiating PMR from EORA.

Main Methods:

  • A comparative study involving 15 PMR patients and 7 EORA patients who underwent FDG-PET/CT.
  • Analysis of abnormal FDG accumulation sites and SUVmax between the two groups.
  • Evaluation of a PET/CT score across 9 specific anatomical sites.

Main Results:

  • Significantly higher FDG accumulation was observed in PMR patients at 9 specific sites, including joints and entheses.
  • The median PET/CT score was significantly higher in the PMR group (8) compared to the EORA group (0).
  • ROC analysis indicated a PET/CT score of 5 achieved 86.7% sensitivity and 86.7% specificity for differentiating PMR from EORA.

Conclusions:

  • FDG-PET/CT is a valuable imaging modality for differentiating PMR from EORA.
  • Abnormal FDG uptake at entheses in PMR patients suggests the presence of enthesitis, alongside bursitis and synovitis.

Related Concept Videos